MedPath

Mycozyl AL

Mycozyl AL

Approved
Approval ID

07edd043-4ac4-b2de-e063-6394a90af25d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 17, 2023

Manufacturers
FDA

PURETEK CORPORATION

DUNS: 785961046

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tolnaftate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59088-443
Product Classification
G
Generic Name
Tolnaftate
Product Specifications
Route of AdministrationTOPICAL
Effective DateOctober 17, 2023
FDA Product Classification

INGREDIENTS (12)

.ALPHA.-TOCOPHEROL ACETATE, DL-Inactive
Code: WR1WPI7EW8
Classification: IACT
LAURETH-4Inactive
Code: 6HQ855798J
Classification: IACT
EUCALYPTUS OILInactive
Code: 2R04ONI662
Classification: IACT
TOLNAFTATEActive
Quantity: 0.1 g in 10 mL
Code: 06KB629TKV
Classification: ACTIB
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TEA TREE OILInactive
Code: VIF565UC2G
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
DIMETHYL SULFOXIDEInactive
Code: YOW8V9698H
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
APPLE CIDER VINEGARInactive
Code: 0UE22Q87VC
Classification: IACT
ARGAN OILInactive
Code: 4V59G5UW9X
Classification: IACT
LAVENDER OILInactive
Code: ZBP1YXW0H8
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mycozyl AL - FDA Drug Approval Details